March 25, 2020
Rubenstein Partners, L.P. recently closed more than 100,000 feet of leasing activity at Makefield Crossing in the Philadelphia suburb of Yardley, PA. At the same time, Rubenstein announced the commencement of interior renovations and exterior plaza improvements to the complex.
Within the past 12 months, Rubenstein has signed a new lease for 21,082 square feet with Biohaven Pharmaceuticals, a 21,690-square-foot renewal and expansion of Cello Health, and a 22,409-square-foot renewal and expansion of Jubilant Pharma, among other deals.
“New and existing tenants have embraced our previously announced capital improvement plan for Makefield Crossing, which we are now executing after securing unanimous approvals from the township,” said Louis Merlini, VP of asset management at Rubenstein.
JLL handles leasing for Makefield Crossing on behalf of Rubenstein, which owns three of the complex’s four buildings. EVPs Doug Newbert and Mike MacCrory lead the JLL team.
For comments, questions or concerns, please contact Paul Bubny